U.S. lifts pause on Johnson & Johnson COVID-19 vaccine
CBSN
Federal health agencies say they are ending their recommended pause on use of Johnson & Johnson's Janssen vaccine, following the vote of a panel of advisers to the Centers for Disease Control and Prevention on resuming the single-shot vaccine.
The Food and Drug Administration says they have revised their emergency use authorization for the vaccine to include a new warning about the "plausible" risk of rare but serious blood clots in adult women under 50. A panel of advisers to the Centers for Disease Control and Prevention voted earlier Friday to recommend resuming use of the Johnson & Johnson vaccine. The shots are expected to be accompanied by a new warning about an increased risk of rare but serious blood clots for adult women under 50.More Related News

The Trump administration deployed ICE and other Homeland Security agents to 14 of the nation's airports on Monday to help shuttle passengers through overcrowded TSA checkpoints. In one airport, the security line wait-time was up to six hours. Nicole Sganga and Kaia Hubbard contributed to this report. In:












